Determinants of IBD-related disability: a cross-sectional survey from the GETAID
- PMID: 33817819
- DOI: 10.1111/apt.16353
Determinants of IBD-related disability: a cross-sectional survey from the GETAID
Abstract
Background: The burden of inflammatory bowel disease (IBD) is rising worldwide. The goal of IBD treatment is to achieve clinical and endoscopic remission but also prevent disability.
Aims: To identify the predictive factors of disability in a large population of patients with IBD.
Patients and methods: We conducted a cross-sectional survey in 42 tertiary centres in France and Belgium. A self-administered questionnaire was designed to explore patients and their IBD characteristics. IBD-disk is a validated tool to measure disability in patients with IBD. The IBD-disk score was then calculated for each patient. Based on a previous study, an overall IBD-disk score ≥40 was associated with moderate-to-severe disability.
Results: Among the 2011 patients, 1700 were analysed, including 746 (44%) in self-reported clinical remission and 752 (44.2%) declaring clinical activity. The patient global assessment of global remission was missing in 200 (11.8%) of 1700 patients. Moderate-to-severe disability was significantly increased in patients with BMI >25 kg/m2 (OR = 1.66; 95% CI [1.29-2.14]), in those having perception of need for a psychotherapist (OR = 2.24; 95% CI [1.79-3.05]) and social worker (OR = 1.54; 95% CI [1.08-2.21]). Conversely, male gender (OR = 0.83; 95% CI [0.69-0.99]), ulcerative colitis (OR = 0.69; 95% CI [0.53-0.92]), self-reported clinical remission (OR = 0.59; 95% CI [0.46-0.77]) and employed or student occupational status (OR = 0.69; 95% CI [0.52-0.92]) were inversely correlated with disability. Overall, 257 (34.5%) patients who declared being in clinical remission had disability.
Conclusion: Determinants of IBD-related disability include IBD-related factors but also psychological and social factors. This highlights the importance of a multidisciplinary team in the management of patients with IBD.
© 2021 John Wiley & Sons Ltd.
Comment in
-
Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply.Aliment Pharmacol Ther. 2021 Jun;53(12):1323. doi: 10.1111/apt.16384. Aliment Pharmacol Ther. 2021. PMID: 34029412 No abstract available.
-
Editorial: determining disability in IBD - 'See(k) and you shall find'.Aliment Pharmacol Ther. 2021 Jun;53(12):1321-1322. doi: 10.1111/apt.16367. Aliment Pharmacol Ther. 2021. PMID: 34029415 No abstract available.
References
REFERENCES
-
- Ramos A, Calvet X, Sicilia B, Vergara M, Villoria A, Gomollo F. IBD-related work disability in the community: prevalence, severity and predictive factors. A cross-sectional study. United Eur Gastroenterol J. 2015;3:335-342.
-
- Paulides E, Frampton C, Gearry B. Overcoming workplace disability in IBD patients: an observational study. Inflamm Intest Dis. 2020;5:84-92.
-
- Morreale GC, Calvaruso V, Sanfratello A, Cappello M. P658 The Inflammatory Bowel Disease Disability Index (IBD-DI) in ulcerative colitis is related to disease activity, need of immunosuppressive therapy and quality of life. J Crohn’s Colitis. 2017;11:S416.
-
- World Health Organization Geneva. Towards a common language for functioning, disability and health: ICF. Int Classification. 2002;1149:1-22.
-
- Gower-Rousseau C, Sarter H, Savoye G, et al. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort Preliminary steps. Gut. 2017;66:588-596.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical